November 28, 2021

Focus on cephalosporins, penicillins, fluoroquinolones, macrolides, carbapenems, aminoglycosides, sulfonamides

Dublin, Aug 20, 2021 (GLOBE NEWSWIRE) – The report “Global Antibiotics Market (2021-2026) by Product Type, Spectrum, Mechanism of Action, Geography, Competitive Analysis and Impact of Covid-19 with Ansoff Analysis” has been added to ResearchAndMarkets.com offer.

The global antibiotics market is estimated at USD 39.2 billion in 2021 and is expected to reach USD 56.15 billion by 2026, with a CAGR of 7.45%.

Market dynamics

The increased incidence of infectious diseases such as lower respiratory tract infections, pneumonia, malaria, and tuberculosis among others are important factors that are boosting the growth of the global antibiotics market.

In addition, the growing burden of diseases linked to different infections is pushing the government and non-governmental organizations to engage in R&D projects, accelerate the discovery of new antibiotics and support regulatory policies to speed up the approval process. . Research funding is the engine of market growth.

For example, BARDA has partnered with the government to fund several companies to develop new treatments for infectious diseases. In addition, the advancement of antibiotic drugs, innovation and collaboration of major players are expected to create new opportunities for the global antibiotics market.

However, factors like overuse of antibiotics and side effects like rash, sore throat, breathing problems, nausea, vomiting, etc. as well as the time taken for regulatory approval, limit market growth. Furthermore, the lack of knowledge of the public regarding the use of antibiotics is the factor that can create challenges for the growth of the global antibiotics market.

Market segmentation

The global antibiotics market is further segmented on the basis of product type, spectrum, mechanism of action, and geography.

By product type, the market is categorized into cephalosporins, penicillins, fluoroquinolones, macrolides, carbapenems, aminoglycosides, sulfonamides, and others. Among all, the penicillins segment is expected to hold the highest market share during the forecast period.

By spectrum, the market is categorized into Broad Spectrum Antibiotics and Narrow Spectrum Antibiotics. Among the two, the broad spectrum antibiotics segment is expected to hold the highest market share during the forecast period.

By Mechanism of Action, the market is categorized into DNA Synthesis Inhibitors, Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, Mycolic Acid Inhibitors, Synthesis Inhibitors RNA and others. Among all, the protein synthesis inhibitors segment is expected to hold the highest market share during the forecast period.

By geography, North America is expected to dominate the market.

Recent developments

1. Melinta Therapeutics Announces FDA Approval of KIMYRSA (oritavancin). – March 15, 2021
2. Amneal Pharmaceuticals, Inc. has completed the previously announced acquisition of a 98% interest in Kashiv Specialty Pharmaceuticals. – April 5, 2021

Company Profiles

Some of the companies covered in this report are Abbott Laboratories, Akron Incorporated, Amneal Pharmaceuticals LLC, Astellas Pharma, Inc, Bausch Health Companies, Inc, Bayer AG, etc.

Main topics covered:

1 Description of the report
1.1 Study objectives
1.2 Market definition
1.3 Currency
1.4 years taken into account
1.5 Language
1.6 Key shareholders

2 Research methodology
2.1 Research process
2.2 Data collection and validation
2.3 Market size estimate
2.4 Study hypotheses
2.5 Limitations of the study

3 Executive summary
3.1 Presentation
3.2 Market size and segmentation
3.3 Market outlook

4 market influencers
4.1 Drivers
4.1.1 Increase in the number of patients with infectious diseases
4.1.2 Government initiatives in the health sector
4.2 Constraints
4.2.1 Side effects caused by the use of antibiotics
4.3 Opportunities
4.3.1 Increase R&D in new drugs
4.3.2 Growing health sectors in developing countries
4.4 challenges
4.4.1 Misuse of antibiotics
4.4.2 Strict government-imposed regulations
4.5 Trends

5 Market analysis
5.1 Regulatory scenario
5.2 Porter’s five forces analysis
5.3 Impact of COVID-19
5.4 Ansoff matrix analysis

6 Global Antibiotics Market, By Product Type
6.1 Presentation
6.2 Cephalosporins
6.3 Penicillins
6.4 Fluoroquinolones
6.5 Macrolides
6.6 Carbapenems
6.7 Aminoglycosides
6.8 Sulfonamides
6.9 Others

7 Global Antibiotics Market, By Spectrum
7.1 Presentation
7.2 Broad spectrum antibiotics
7.3 Narrow-spectrum antibiotics

8 Global Antibiotics Market, by Mechanism of Action
8.1 Presentation
8.2 DNA synthesis inhibitors
8.3 Protein synthesis inhibitors
8.4 Inhibitors of cell wall synthesis
8.5 Mycolic acid inhibitors
8.6 RNA synthesis inhibitors
8.7 Others

9 Global Antibiotics Market, By Geography
9.1 Presentation

10 Competitive landscape
10.1 Competitive quadrant
10.2 Market share analysis
10.3 Strategic initiatives

11 company profiles

  • Abbott Laboratories

  • Aurobindo Pharma

  • Akron Incorporated

  • Amneal Pharmaceuticals LLC

  • Astellas Pharma, Inc

  • Bausch Healthcare Companies, Inc

  • Bayer AG

  • Bristol-Myers Squibb Company

  • Cadila Health Ltd.

  • Eli Lilly and company

  • F. Hoffmann-La Roche SA

  • Johnson & johnson

  • KYORIN Holdings, Inc

  • LG Chem Ltd

  • Lupine Limited

  • Melinta Therapeutics, Inc

  • Merck & Co Inc

  • MerLion Pharmaceuticals GmbH

  • Mylan NV

  • Novartis International SA

  • Pfizer Inc

  • Sanofi SA

  • Shionogi & Co., Ltd

  • Sun Pharmaceutical Industries Limited

  • Teva Pharmaceutical Industries Ltd.

For more information on this report, visit https://www.researchandmarkets.com/r/lyfxne

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Source link